PR NEWSWIRE

Previous Stories

Pepperstone Group is pleased to announce their pledge to be Carbon Neutral by FY23

Nov 30 2021 - PR NewsWire

DOCKLANDS, Australia, Nov. 30, 2021 /PRNewswire/ – With the growing focus on climate change and pledges by the United Nations, leading…


Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive

Nov 30 2021 - PR NewsWire

ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA)…


Q-Sera enters exclusive agreement with Terumo Corporation for RAPClot™ rapid serum blood collection tube technology in Japan

Nov 30 2021 - PR NewsWire

MELBOURNE, Australia, Nov. 30, 2021 /PRNewswire/ – Q-Sera Pty Ltd, an Australian venture-backed company, today announced a partnership with Terumo Corporation,…


Truck-Lite Parent Clarience Technologies Acquires Australian-based LED Autolamps

Nov 30 2021 - PR NewsWire

Move Expands Overall Global Footprint, Strengthens Presence in Australia, Europe SOUTHFIELD, Mich., Nov. 30, 2021 /PRNewswire/ – Clarience Technologies™, parent company…


GBM AGILE Opens to Paxalisib in Canada

Nov 30 2021 - PR NewsWire

SYDNEY, Nov. 29, 2021 /PRNewswire/ – Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to…


CRRC and the University of Queensland Establish CRRC Merit Scholarship to Support Students of Faculty of Engineering

Nov 29 2021 - PR NewsWire

BEIJING, Nov. 29, 2021 /PRNewswire/ — CRRC Group Co., Ltd. ("CRRC") and the University of Queensland (UQ) has announced the…


Australian Ethical (ASX:AEF) doubles down on climate & tech solutions with inaugural 2021 Visionary Grants

Nov 29 2021 - PR NewsWire

SYDNEY, Nov. 29, 2021 /PRNewswire/ – Australia’s original responsible investment and super fund manager Australian Ethical has, through its philanthropic entity…


Australian biotech company Starpharma announces positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel

Nov 26 2021 - PR NewsWire

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ — Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had…


Starpharma releases positive DEP® phase 2 interim results in prostate cancer

Nov 26 2021 - PR NewsWire

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ — Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort…


CI&T Wins Global Open Finance Challenge with Financial Passport Solution for Immigrants

Nov 26 2021 - PR NewsWire

CI&T’s NoFrontiers team developed an unprecedented solution aimed at newcomers to a foreign country BRISBANE, Australia, Nov. 26, 2021 /PRNewswire/ —…


Analyse The Market From A Different Angle